This blog posting represents the views of the author, David Fosberry. Those opinions may change over time. They do not constitute an expert legal or financial opinion.

If you have comments on this blog posting, please email me .

The Opinion Blog is organised by threads, so each post is identified by a thread number ("Major" index) and a post number ("Minor" index). If you want to view the index of blogs, click here to download it as an Excel spreadsheet.

Click here to see the whole Opinion Blog.

To view, save, share or refer to a particular blog post, use the link in that post (below/right, where it says "Show only this post").

Round-up of Covid-19 news.

Posted on 17th January 2021

Show only this post
Show all posts in this thread (Covid-19).

Vaccines and Immunity

This article by the BBC reports that the Chinese vaccine, Sinovac, has been shown to be 50.4% effective in clinical trials in Brazil. 50.4% is not great, compared to the figures for the vaccines from Pfizer, Moderna and AstraZeneca, but still better than nothing.

Moderna claims that its coronavirus vaccine will provide immunity from the disease for at least one year, as reported here on Axios and here on BGR. A year or more is way better than the 4 to 6 months that experts originally estimated for the vaccines.

This piece on The New York Times reports that the Pfizer vaccine works against key Covid-19 mutations, including those found in Britain and South Africa.

A BioTech firm, IosBio - based in Sussex, England, has announced that it is developing a Covid-19 vaccine in the form of a pill, as described here by The Irish Post. The company is currently testing the immunisation pill in clinical trials.

Analysis of data about the 3.2 million recorded cases of Covid-19 in the UK to date has shown that infection provides around 5 months protection from reinfection by the coronavirus, as reported here on Cosmopolitan.


This article on the Hindustani Times reports that the use of the diabetes drug metformin, before a diagnosis of Covid-19, is associated with a threefold decrease in mortality in Covid-19 patients with type 2 diabetes, according to a racially diverse study at the University of Alabama at Birmingham. Metformin is used to treat type 2 diabetes which is not severe enough to justify insulin injections (I take it myself). "The mechanisms may involve metformin's previously described anti-inflammatory and anti-thrombotic effects", since anti-inflammatory and anti-thrombotic drugs are now a standard part of the treatment protocol for the coronavirus.

A large clinical trial has begun in the UK of inhalable interferon beta, as reported here by the BBC. This treatment is intended for patients hospitalised due to Covid-19; it costs £2,000 for a course of treatment.

The BBC reports, here, that two anti-inflammatory drugs, tocilizumab and sariluma can cut deaths by a quarter in patients who are sickest with Covid. The drugs each cost around £750 to £1,000 for a course of treatment. The recommendation seems to be to administer these two drugs in addition to dexamethasone (way cheaper, at £5 for a course of treatment).

This report on BGR describes how doctors have begun experimenting with the use of stem-cell treatments for severely ill Covid-19 patients, with some success. These are not, however, proper clinical trials; such clinical trials would need to be successfully concluded before this treatment is approved and made widely available, which takes significant time.


This report on "Eat This, Not That" mentions the research done and ongoing on the use of vitamin and mineral supplements (vitamin C, D, B6, zinc and magnesium) to prevent severe infections of Covid-19, although some of the trials have been inconclusive, and have contradictory results. There shouldn't be any surprises here: many people are at least lightly deficient in vitamins and minerals, due to poor diet and the impact of processed food. For such people, taking supplements is likely to boost their immunity - Duh!

A report from New Atlas, here, a study investigating the relationship between COVID-19 severity and the gut microbiome. The observational research suggests specific microbial patterns correlate with disease severity and those bacterial imbalances may account for some cases of “long COVID”. Again (as above), if you are healthy, you are not so likely to get severely ill from an infection.

Having Covid-19

This article by The Mirror describes 10 signs that you may have already had Covid and may therefore be protected (immune) for up to 5 months.

There have been several articles about the potential long term effects of a Covid-19 infection:

  • Mashable reports, here, and New Atlas, here, that 3 in 4 recovered Covid-19 patients (people who were hospitalised) suffer from symptoms 6 months later. These symptoms include fatigue, muscle weakness, sleeping difficulties, anxiety, depression, "chest imaging abnormalities", chronic coughs, shortness of breath, chest tightness, and cognitive dysfunction.
  • Medical News Today reports, here, that Covid-19 infection might increase the risk of long-term neurological problems, including cognitive decline and dementia.

The Future

CNBC reports, here, on the prediction by the CEO of Moderna that Covid-19 and the resulting and overwhelmed hospitals will be with us forever, and that Covid-19 will become an endemic disease, meaning it will become present in communities at all times, though likely at lower levels than it is now. This would mean the wearing of masks and social distancing will be our lives forever, and that travel will be much rarer and riskier than it used to be.

Taking a slightly less pessimistic tone is this report on "Mic", which says that Covid-19 may become nothing more than an annoying, common cold-like illness. I guess that would be after the coronavirus has killed most of the more vulnerable people, or nearly everyone has been vaccinated.